Complete Filing Data
Erasca, Inc. reported Stockholders Equity of $325.17 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Erasca, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$124.5M | -$161.7M | -$125.0M | -$242.8M | -$122.8M | -$101.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $223.0K | $328.0K | $1.1M | -$879.0K | -$164.0K | -$9.0K |
| Research And Development Expense Excluding Acquired In Process Cost | $92.9M | $115.4M | $103.8M | $112.5M | $73.9M | $29.6M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $223.0K | $328.0K | $1.1M | -$879.0K | -$164.0K | -$9.0K |
| Operating Income Loss | -$140.9M | -$179.6M | -$141.5M | -$247.5M | -$124.9M | -$109.3M |
| Operating Expenses | $140.9M | $179.6M | $141.5M | $247.5M | $124.9M | $109.3M |
| Nonoperating Income Expense | $16.4M | $17.9M | $16.5M | $4.6M | $2.1M | $7.6M |
| Interest Income Expense Nonoperating Net | $16.6M | $20.1M | $16.7M | $4.9M | $190.0K | $336.0K |
| General And Administrative Expense | $38.6M | $41.7M | $37.7M | $33.0M | $22.6M | $8.0M |
| Comprehensive Income Net Of Tax | -$124.3M | -$161.3M | -$123.9M | -$243.7M | -$122.9M | -$101.7M |
| Other Nonoperating Expense | $248.0K | $2.2M | $229.0K | $257.0K | ||
| Research And Development In Process | $102.0M | $10.8M | $71.7M | |||
| In Process Research And Development Expense | $9.5M | $22.5M | $102.0M | |||
| Other Nonoperating Income Expense | -$257.0K | $314.0K | -$102.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$30.6M | -$33.9M | -$31.0M | -$31.2M | -$63.2M | -$35.0M | -$30.4M | -$31.8M | -$33.2M | -$35.5M | -$35.6M | -$36.5M | -$46.1M | -$28.2M | -$18.0M | -$10.6M | -$5.5M | -$23.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $234.0K | -$213.0K | $223.0K | $2.0M | $14.0K | -$287.0K | $218.0K | -$279.0K | $527.0K | -$156.0K | -$272.0K | -$789.0K | $1.0K | -$2.0K | -$1.0K | $3.0K | $8.0K | -$22.0K |
| Research And Development Expense Excluding Acquired In Process Cost | $22.5M | $21.2M | $26.0M | $27.6M | $33.0M | $28.6M | $25.2M | $26.2M | $27.6M | $28.2M | $27.5M | $27.4M | $20.0M | $17.6M | $12.2M | $9.1M | $5.9M | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $234.0K | -$213.0K | $223.0K | $2.0M | $14.0K | -$287.0K | $218.0K | -$279.0K | $527.0K | -$156.0K | -$272.0K | -$789.0K | $1.0K | -$2.0K | -$1.0K | $3.0K | $8.0K | |
| Operating Income Loss | -$34.5M | -$38.1M | -$35.6M | -$37.2M | -$67.8M | -$38.9M | -$34.7M | -$36.0M | -$37.0M | -$37.0M | -$35.9M | -$36.5M | -$46.0M | -$28.2M | -$19.6M | -$11.2M | -$7.3M | |
| Operating Expenses | $34.5M | $38.1M | $35.6M | $37.2M | $67.8M | $38.9M | $34.7M | $36.0M | $37.0M | $37.0M | $35.9M | $36.5M | $46.0M | $28.2M | $19.6M | $11.2M | $7.3M | |
| Nonoperating Income Expense | $3.9M | $4.2M | $4.7M | $6.0M | $4.6M | $3.8M | $4.3M | $4.2M | $3.8M | $1.5M | $297.0K | $47.0K | -$25.0K | -$30.0K | $1.6M | $555.0K | $1.8M | |
| Interest Income Expense Nonoperating Net | $4.0M | $4.3M | $4.7M | $5.9M | $5.0M | $3.9M | $4.3M | $4.3M | $3.9M | $1.5M | $388.0K | $114.0K | $49.0K | $31.0K | $30.0K | $38.0K | $70.0K | |
| General And Administrative Expense | $10.1M | $9.5M | $9.7M | $9.6M | $12.3M | $10.3M | $9.4M | $9.8M | $9.4M | $8.8M | $8.4M | $7.1M | $6.9M | $5.1M | $3.7M | $2.0M | $1.4M | |
| Comprehensive Income Net Of Tax | -$30.4M | -$34.1M | -$30.7M | -$29.2M | -$63.2M | -$35.3M | -$30.1M | -$32.1M | -$32.7M | -$35.6M | -$35.9M | -$37.2M | -$46.1M | -$28.2M | -$18.0M | -$10.6M | -$5.5M | |
| Other Nonoperating Expense | $81.0K | $76.0K | $460.0K | $66.0K | $49.0K | $62.0K | $51.0K | $49.0K | $91.0K | $67.0K | $74.0K | $61.0K | $55.0K | $38.0K | $33.0K | |||
| Research And Development In Process | $2.0M | $1.7M | $5.5M | $3.7M | $75.0K | |||||||||||||
| In Process Research And Development Expense | $2.0M | $7.5M | $0.00 | $22.5M | ||||||||||||||
| Other Nonoperating Income Expense | -$37.0K | $173.0K | -$49.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $325.2M | $423.5M | $316.7M | $411.9M | $456.5M | -$114.0M | -$13.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $74.2M | $68.1M | $93.5M | $284.6M | $360.9M | $65.7M | $29.6M |
| Cash And Cash Equivalents At Carrying Value | $73.8M | $67.7M | $93.1M | $284.2M | $360.5M | $65.4M | |
| Retained Earnings Accumulated Deficit | -$892.2M | -$767.7M | -$606.0M | -$481.0M | -$238.2M | -$115.4M | |
| Restricted Cash Noncurrent | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $312.0K | |
| Property Plant And Equipment Net | $13.3M | $16.3M | $22.3M | $24.8M | $16.0M | $1.8M | |
| Prepaid Expense And Other Assets Current | $10.2M | $10.5M | $8.3M | $8.9M | $5.5M | $1.3M | |
| Other Assets Noncurrent | $1.5M | $2.6M | $4.4M | $4.8M | $2.9M | $451.0K | |
| Operating Lease Right Of Use Asset | $29.0M | $32.2M | $37.9M | $40.4M | $17.4M | $2.2M | |
| Operating Lease Liability Noncurrent | $42.1M | $47.3M | $51.9M | $53.8M | $18.5M | $2.1M | |
| Operating Lease Liability Current | $5.1M | $4.6M | $4.0M | $1.3M | $285.0K | $877.0K | |
| Liabilities Current | $28.5M | $31.4M | $26.2M | $48.7M | $26.2M | $13.7M | |
| Liabilities And Stockholders Equity | $396.2M | $502.5M | $395.3M | $514.9M | $501.4M | $124.8M | |
| Liabilities | $71.0M | $79.0M | $78.6M | $103.1M | $44.9M | $17.4M | |
| Common Stock Value | $28.0K | $28.0K | $15.0K | $15.0K | $12.0K | $3.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $6.1M | -$25.3M | -$191.1M | -$76.3M | $295.2M | $36.1M | |
| Assets Current | $286.2M | $308.8M | $320.7M | $444.5M | $420.0M | $120.0M | |
| Assets | $396.2M | $502.5M | $395.3M | $514.9M | $501.4M | $124.8M | |
| Additional Paid In Capital Common Stock | $1.22B | $1.19B | $922.6M | $893.9M | $694.8M | $1.4M | |
| Accrued Liabilities And Other Liabilities | $22.5M | $26.3M | $20.2M | $24.3M | $21.3M | $11.9M | |
| Accretion Amortization Of Discounts And Premiums Investments | $5.1M | $9.6M | $7.0M | $994.0K | -$108.0K | $38.0K | |
| Accounts Payable Current | $981.0K | $468.0K | $2.0M | $23.0M | $4.7M | $878.0K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $628.0K | $405.0K | $77.0K | -$1.0M | -$162.0K | $2.0K | |
| Marketable Securities Current | $202.3M | $230.6M | $219.3M | $151.4M | $54.0M | ||
| Other Liabilities Noncurrent | $399.0K | $362.0K | $566.0K | $573.0K | $158.0K | ||
| Marketable Securities Noncurrent | $65.7M | $142.2M | $9.6M | $44.8M | |||
| Amounts Accrued For Purchase Of Property And Equipment | $13.0K | $800.0K | $3.8M | $74.0K | |||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $22.7M | $17.5M | $28.0K | ||||
| Change In Fair Value Of Preferred Stock Purchase Right Liability | $1.6M | $7.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $347.9M | $372.3M | $399.5M | $450.0M | $451.1M | $288.4M | $339.0M | $362.7M | $386.5M | $365.3M | $395.1M | $424.7M | $483.0M | -$150.0M | -$129.3M | -$52.8M | -$42.6M | -$37.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $70.6M | $66.6M | $70.9M | $69.3M | $173.2M | $77.1M | $113.3M | $139.2M | $273.2M | $219.7M | $298.4M | $333.8M | $446.2M | $156.8M | $170.4M | $62.3M | $104.3M | |
| Cash And Cash Equivalents At Carrying Value | $70.2M | $66.1M | $70.5M | $68.9M | $172.8M | $172.8M | $112.9M | $138.8M | $272.8M | $219.3M | $219.3M | $333.3M | $445.8M | $156.4M | $170.0M | $62.0M | $104.3M | |
| Retained Earnings Accumulated Deficit | -$863.1M | -$832.5M | -$798.6M | -$735.4M | -$704.2M | -$641.0M | -$576.3M | -$546.0M | -$514.2M | -$345.7M | -$310.2M | -$274.6M | -$207.7M | -$161.6M | ||||
| Restricted Cash Noncurrent | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | $408.0K | ||||
| Property Plant And Equipment Net | $14.0M | $14.8M | $15.6M | $17.2M | $18.0M | $21.4M | $23.2M | $23.9M | $24.6M | $24.9M | $24.2M | $20.4M | $8.5M | $2.3M | ||||
| Prepaid Expense And Other Assets Current | $11.5M | $10.0M | $10.0M | $11.3M | $9.6M | $8.9M | $9.3M | $6.6M | $8.1M | $9.8M | $9.9M | $10.8M | $5.7M | $3.6M | ||||
| Other Assets Noncurrent | $2.0M | $2.6M | $2.6M | $3.9M | $4.0M | $4.5M | $4.4M | $5.2M | $4.8M | $4.8M | $4.7M | $5.1M | $1.7M | $3.6M | ||||
| Operating Lease Right Of Use Asset | $30.1M | $30.8M | $31.5M | $32.9M | $33.5M | $37.2M | $38.5M | $39.2M | $39.8M | $41.1M | $14.8M | $16.9M | $19.0M | $1.9M | ||||
| Operating Lease Liability Noncurrent | $43.4M | $44.7M | $46.0M | $48.5M | $49.7M | $50.8M | $52.9M | $54.0M | $54.9M | $53.4M | $27.4M | $29.4M | $19.4M | $1.7M | ||||
| Operating Lease Liability Current | $4.9M | $4.7M | $4.8M | $4.5M | $4.3M | $4.1M | $3.8M | $3.7M | $3.1M | $1.0M | $201.0K | $14.0K | $864.0K | $888.0K | ||||
| Liabilities Current | $28.7M | $28.2M | $25.5M | $30.0M | $24.9M | $30.2M | $26.7M | $23.3M | $25.5M | $27.7M | $22.3M | $21.4M | $19.6M | $17.9M | ||||
| Liabilities And Stockholders Equity | $420.4M | $445.4M | $471.2M | $528.9M | $525.7M | $370.0M | $419.4M | $440.7M | $467.5M | $446.4M | $444.8M | $475.5M | $521.9M | $210.4M | ||||
| Liabilities | $72.5M | $73.1M | $71.7M | $78.9M | $74.7M | $81.6M | $80.4M | $78.0M | $81.1M | $81.1M | $49.8M | $50.8M | $39.0M | $19.6M | ||||
| Common Stock Value | $28.0K | $28.0K | $28.0K | $28.0K | $27.0K | $15.0K | $15.0K | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $12.0K | $3.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.7M | -$16.3M | -$11.5M | -$27.1M | $104.7M | |||||||||||||
| Assets Current | $299.9M | $310.7M | $314.6M | $330.2M | $418.0M | $306.6M | $306.0M | $323.9M | $397.9M | $365.8M | $381.4M | $403.4M | $492.3M | $197.3M | ||||
| Assets | $420.4M | $445.4M | $471.2M | $528.9M | $525.7M | $370.0M | $419.4M | $440.7M | $467.5M | $446.4M | $444.8M | $475.5M | $521.9M | $210.4M | ||||
| Additional Paid In Capital Common Stock | $1.21B | $1.20B | $1.20B | $1.18B | $1.16B | $929.6M | $915.8M | $909.4M | $901.1M | $712.4M | $706.5M | $700.2M | $690.7M | $11.6M | ||||
| Accrued Liabilities And Other Liabilities | $20.8M | $21.8M | $18.4M | $23.2M | $18.5M | $16.6M | $19.2M | $17.0M | $19.1M | $22.3M | $19.8M | $16.7M | $17.4M | $15.5M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.0M | $2.3M | $975.0K | -$17.0K | -$13.0K | |||||||||||||
| Accounts Payable Current | $3.0M | $1.7M | $2.3M | $2.4M | $2.1M | $2.6M | $3.7M | $2.6M | $3.4M | $4.3M | $2.3M | $4.7M | $1.3M | $1.5M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $649.0K | $415.0K | $628.0K | $1.8M | -$196.0K | -$210.0K | -$575.0K | -$793.0K | -$514.0K | -$1.4M | -$1.2M | -$951.0K | -$1.0K | |||||
| Marketable Securities Current | $218.2M | $234.5M | $234.1M | $250.0M | $235.6M | $221.0M | $183.8M | $178.5M | $117.0M | $136.7M | $73.5M | $59.2M | ||||||
| Other Liabilities Noncurrent | $395.0K | $263.0K | $251.0K | $340.0K | $82.0K | $559.0K | $761.0K | $697.0K | $630.0K | |||||||||
| Marketable Securities Noncurrent | $74.0M | $86.1M | $106.5M | $144.4M | $51.8M | $46.9M | $48.1M | $9.6M | $19.3M | $29.2M | ||||||||
| Amounts Accrued For Purchase Of Property And Equipment | $38.0K | $1.3M | ||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | ||||||||||||||||||
| Change In Fair Value Of Preferred Stock Purchase Right Liability | $1.6M | $555.0K | $1.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $3.1M | $3.8M | $3.7M | $2.6M | $829.0K | $540.0K |
| Share Based Compensation | $24.9M | $27.0M | $26.2M | $20.1M | $8.3M | $797.0K |
| Proceeds From Stock Options Exercised | $372.0K | $836.0K | $505.0K | $2.0M | $1.4M | $3.0M |
| Payments To Acquire Property Plant And Equipment | $128.0K | $60.0K | $1.8M | $14.6M | $11.2M | $947.0K |
| Net Cash Provided By Used In Operating Activities | -$95.5M | -$109.4M | -$101.2M | -$103.3M | -$79.6M | -$32.7M |
| Net Cash Provided By Used In Investing Activities | $100.4M | -$156.6M | -$91.2M | -$71.1M | -$64.6M | -$71.2M |
| Net Cash Provided By Used In Financing Activities | $1.1M | $240.7M | $1.3M | $98.1M | $439.4M | $140.0M |
| Increase Decrease In Prepaid Expenses And Other Current And Long Term Assets | -$1.8M | $2.4M | -$939.0K | $3.6M | $6.7M | $930.0K |
| Increase Decrease In Operating Lease Assets And Liabilities Net | $1.9M | $732.0K | -$3.1M | -$13.7M | -$1.2M | $95.0K |
| Increase Decrease In Accounts Payable | $513.0K | -$1.5M | -$886.0K | $676.0K | $1.3M | -$380.0K |
| Payments To Acquire In Process Research And Development | $9.5M | $22.5M | $20.0M | $2.0M | $7.7M | $37.7M |
| Proceeds From Sale And Maturity Of Marketable Securities | $261.0M | $269.3M | $244.9M | $79.8M | $60.1M | |
| Payments To Acquire Marketable Securities | $151.0M | $403.2M | $314.4M | $132.3M | $105.8M | |
| Increase Decrease In Accrued Expenses And Other Current And Long Term Liabilities | -$3.8M | $6.4M | -$2.3M | $5.0M | $11.9M | |
| Proceeds From Issuance Of Common Stock Under The Employee Stock Purchase Plan | $724.0K | $800.0K | $790.0K | $820.0K | $1.1M | |
| Payments To Acquire Equity Securities Fv Ni | $157.0K | $2.0M | ||||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $11.9M | $4.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $755.0K | $787.0K | $822.0K | $842.0K | $1.1M | $998.0K | $941.0K | $955.0K | $894.0K | $771.0K | $534.0K | $403.0K | $191.0K | $169.0K | $149.0K | $139.0K | $134.0K |
| Share Based Compensation | $6.7M | $6.8M | $6.8M | $4.4M | $795.0K | ||||||||||||
| Proceeds From Stock Options Exercised | $33.0K | $24.0K | $183.0K | $460.0K | $1.1M | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $83.0K | $42.0K | $1.2M | $7.3M | $122.0K | ||||||||||||
| Net Cash Provided By Used In Operating Activities | -$31.6M | -$33.3M | -$26.4M | -$25.8M | -$15.7M | ||||||||||||
| Net Cash Provided By Used In Investing Activities | $34.3M | $10.0M | $14.7M | -$1.8M | -$162.0K | ||||||||||||
| Net Cash Provided By Used In Financing Activities | $33.0K | $6.9M | $183.0K | $460.0K | $120.5M | ||||||||||||
| Increase Decrease In Prepaid Expenses And Other Current And Long Term Assets | -$459.0K | $507.0K | -$670.0K | $5.5M | $1.2M | ||||||||||||
| Increase Decrease In Operating Lease Assets And Liabilities Net | $385.0K | $238.0K | -$3.3M | -$11.1M | $41.0K | ||||||||||||
| Increase Decrease In Accounts Payable | $1.8M | $633.0K | $446.0K | $1.9M | $175.0K | ||||||||||||
| Payments To Acquire In Process Research And Development | $20.0M | $2.0M | $6.0M | ||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $45.0M | $54.0M | $60.2M | $19.3M | $28.0M | ||||||||||||
| Payments To Acquire Marketable Securities | $10.7M | $44.0M | $24.3M | $9.8M | $22.0M | ||||||||||||
| Increase Decrease In Accrued Expenses And Other Current And Long Term Liabilities | -$8.0M | -$3.6M | -$4.4M | -$3.7M | |||||||||||||
| Proceeds From Issuance Of Common Stock Under The Employee Stock Purchase Plan | |||||||||||||||||
| Payments To Acquire Equity Securities Fv Ni | $2.0M | ||||||||||||||||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$3.7M | $353.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.44 | -$0.69 | -$0.83 | -$1.99 | -$1.85 | -$4.83 |
| Weighted Average Number Of Shares Outstanding Basic | 283.5M | 233.8M | 150.2M | 122.0M | 66.3M | |
| Weighted Average Number Of Diluted Shares Outstanding | 283.5M | 233.8M | 150.2M | 122.0M | 66.3M | |
| Earnings Per Share Basic | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | |
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 147.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 284.2M | 283.2M | 151.1M | 149.3M | 119.1M | 21.9M |
| Common Stock Shares Issued | 284.2M | 283.2M | 151.5M | 150.4M | 121.4M | 25.2M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 66.3M | 21.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.11 | -$0.12 | -$0.11 | -$0.11 | -$0.29 | -$0.23 | -$0.20 | -$0.21 | -$0.22 | -$0.29 | -$0.30 | -$0.31 | -$0.46 | -$1.20 | -$0.81 | -$0.50 | -$0.26 |
| Weighted Average Number Of Shares Outstanding Basic | 283.7M | 283.4M | 283.3M | 282.4M | 217.8M | 151.2M | 150.5M | 150.0M | 149.5M | 120.8M | 120.2M | 119.5M | 99.1M | 23.5M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 283.7M | 283.4M | 283.3M | 282.4M | 217.8M | 151.2M | 150.5M | 150.0M | 149.5M | 120.8M | 120.2M | 119.5M | 99.1M | 23.5M | |||
| Earnings Per Share Basic | $-0.11 | $-0.12 | $-0.11 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.21 | $-0.22 | $-0.29 | $-0.30 | $-0.31 | $-0.46 | $-1.20 | |||
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 156.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 283.7M | 283.7M | 283.3M | 282.7M | 273.0M | 151.2M | 150.5M | 150.4M | 149.7M | 121.0M | 120.5M | 119.9M | 118.6M | 24.4M | |||
| Common Stock Shares Issued | 283.7M | 283.7M | 283.3M | 282.7M | 273.2M | 151.5M | 151.1M | 151.0M | 150.6M | 122.3M | 122.1M | 121.7M | 121.3M | 27.3M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 119.5M | 99.1M | 23.5M | 22.2M | 21.1M | 20.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $24.9M | $27.0M | $26.2M | $20.1M | $8.3M | $797.0K |
| Stock Issued During Period Value Stock Options Exercised | $372.0K | $836.0K | $505.0K | $2.0M | $335.0K | $170.0K |
| Stock Issued During Period Value Vesting Of Early Exercised Stock Options | $465.0K | $1.2M | $1.2M | $692.0K | $322.0K | |
| Vesting Of Early Exercised Options | $465.0K | $1.2M | $1.2M | $692.0K | $322.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $724.0K | $800.0K | $790.0K | $820.0K | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.0M | $6.4M | $6.7M | $6.6M | $7.2M | $6.8M | $6.2M | $7.0M | $6.8M | $5.2M | $5.1M | $4.4M | $3.0M | $1.6M | $795.0K | $176.0K | $109.0K | $105.0K |
| Stock Issued During Period Value Stock Options Exercised | $41.0K | $43.0K | $33.0K | $311.0K | $105.0K | $24.0K | $7.0K | $122.0K | $183.0K | $427.0K | $375.0K | $460.0K | $21.0K | $180.0K | $94.0K | $114.0K | ||
| Stock Issued During Period Value Vesting Of Early Exercised Stock Options | $155.0K | $155.0K | $155.0K | $168.0K | $652.0K | $243.0K | $238.0K | $238.0K | $479.0K | $171.0K | $174.0K | $174.0K | $45.0K | |||||
| Vesting Of Early Exercised Options | $155.0K | $243.0K | $479.0K | $174.0K | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $404.0K | $395.0K | $527.0K | $617.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.